NFSG Corp Buys 4,818 Shares of Astera Labs, Inc. $ALAB

NFSG Corp grew its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 83.0% in the third quarter, Holdings Channel.com reports. The firm owned 10,623 shares of the company’s stock after acquiring an additional 4,818 shares during the quarter. NFSG Corp’s holdings in Astera Labs were worth $3,781,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. BlackRock Inc. purchased a new stake in shares of Astera Labs in the second quarter valued at about $6,609,581,000. Bank of America Corp DE acquired a new stake in Astera Labs during the second quarter worth about $1,061,791,000. Atreides Management LP raised its stake in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares during the period. Amundi raised its stake in Astera Labs by 77.9% during the first quarter. Amundi now owns 1,880,830 shares of the company’s stock worth $206,139,000 after purchasing an additional 823,477 shares during the period. Finally, Deutsche Bank AG purchased a new position in Astera Labs during the second quarter worth about $325,602,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This represents a 6.68% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 408,558 shares of company stock valued at $127,306,034. 10.40% of the stock is owned by company insiders.

Astera Labs Trading Up 0.6%

ALAB opened at $301.98 on Friday. The stock’s 50-day moving average price is $315.82 and its 200 day moving average price is $297.08. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The firm has a market cap of $52.39 billion, a price-to-earnings ratio of 193.73 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. Astera Labs’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same period last year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts forecast that Astera Labs, Inc. will post 2.70 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ALAB. Needham & Company LLC increased their price target on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Jefferies Financial Group raised their price target on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Stifel Nicolaus lifted their price target on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. Royal Bank Of Canada lifted their price target on shares of Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Finally, Bank of America upped their price objective on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Eleven investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $348.33.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.